Multiple myeloma (MM) is a plasma cell neoplasm that commonly expresses CD38.
Daratumumab (DARA), a human monoclonal antibody targeting CD38, has significantly improved …

CRISPR/Cas9 technology is accelerating genome engineering in many cell types, but so far,
gene delivery and stable gene modification have been challenging in primary NK cells. For …

Antitumor activity of immune cells such as T cells and NK cells has made them auspicious
therapeutic regimens for adaptive cancer immunotherapy. Enhancing their cytotoxic effects …

Genetically modified pigs have been considered favorable resources in xenotransplantation.
Microinjection of randomly integrating transgenes into zygotes, somatic cell nuclear transfer…

The advent of immunotherapy has revolutionized how we manage and treat cancer. While
the majority of immunotherapy-related studies performed to date have focused on adult …

Cancer immunotherapy using genetically modified immune cells such as those expressing
chimeric antigen receptors has shown dramatic outcomes in patients with refractory and …

Human peripheral blood natural killer (NK) cells have intense antitumor activity and have
been used successfully in several clinical trials. Modifying NK cells with a chimeric antigen …

Obesity is associated with changes in the secretome of adipose tissue (AT), which affects
the vasculature through endocrine and paracrine mechanisms. Wingless-related integration …

Human peripheral blood natural killer (NK) cells have intense antitumor activity and have
been used successfully in several clinical trials. Modifying NK cells with a chimeric antigen …

Background The mechanism by which natural killer (NK) cell education results in licensed
NK cells with heightened effector function against missing self-targets is not known. Objective …